Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
New product line to address the challenge of restrictions on use of plastic straws
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
The HD-550 endoscopy system has been available outside of the USA since 2019
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Subscribe To Our Newsletter & Stay Updated